- Home
- ROIV vs BLDR Comparison
ROIV vs BLDR Comparison
Compare ROIV & BLDR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROIV
- BLDR
- Stock Information
- Founded
- ROIV 2014
- BLDR 1998
- Country
- ROIV United Kingdom
- BLDR United States
- Employees
- ROIV 750
- BLDR N/A
- Industry
- ROIV Biotechnology: Pharmaceutical Preparations
- BLDR RETAIL: Building Materials
- Sector
- ROIV Health Care
- BLDR Consumer Discretionary
- Exchange
- ROIV Nasdaq
- BLDR Nasdaq
- Market Cap
- ROIV 14.1B
- BLDR 13.9B
- IPO Year
- ROIV N/A
- BLDR 2005
- Fundamental
- Price
- ROIV $20.73
- BLDR $108.19
- Analyst Decision
- ROIV Strong Buy
- BLDR Buy
- Analyst Count
- ROIV 8
- BLDR 18
- Target Price
- ROIV $21.19
- BLDR $143.89
- AVG Volume (30 Days)
- ROIV 8.4M
- BLDR 2.6M
- Earning Date
- ROIV 11-10-2025
- BLDR 10-30-2025
- Dividend Yield
- ROIV N/A
- BLDR N/A
- EPS Growth
- ROIV N/A
- BLDR N/A
- EPS
- ROIV N/A
- BLDR 5.26
- Revenue
- ROIV $20,329,000.00
- BLDR $15,653,056,000.00
- Revenue This Year
- ROIV N/A
- BLDR N/A
- Revenue Next Year
- ROIV $320.50
- BLDR $0.28
- P/E Ratio
- ROIV N/A
- BLDR $19.12
- Revenue Growth
- ROIV N/A
- BLDR N/A
- 52 Week Low
- ROIV $8.73
- BLDR $94.35
- 52 Week High
- ROIV $21.35
- BLDR $194.36
- Technical
- Relative Strength Index (RSI)
- ROIV 66.63
- BLDR 48.59
- Support Level
- ROIV $19.99
- BLDR $94.35
- Resistance Level
- ROIV $20.99
- BLDR $108.90
- Average True Range (ATR)
- ROIV 0.74
- BLDR 3.92
- MACD
- ROIV -0.19
- BLDR 0.52
- Stochastic Oscillator
- ROIV 56.41
- BLDR 79.03
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About BLDR Builders FirstSource Inc.
Builders FirstSource Inc is a manufacturer and supplier of building materials. The company offers structural and related building products such as factory-built roof and floor trusses, wall panels and stairs, vinyl windows, custom millwork and trim, and engineered wood. The products can be designed for each home individually and are installed by Builders FirstSource. The company's construction-related services include professional installation, turn-key framing, and shell construction. Builders FirstSource's customers range from large production builders to small custom homebuilders.